[1] Bray F, Laversanne M, Sung H, et al.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. [2] Calzado-Martín A, Encinar M, Tamayo J, et al.Effect of actin organization on the stiffness of living breast cancer cells revealed by peak-force modulation atomic force microscopy[J]. ACS Nano, 2016, 10(3): 3365-3374. [3] Kalli M, Poskus MD, Stylianopoulos T, et al.Beyond matrix stiffness: targeting force-induced cancer drug resistance[J]. Trends Cancer, 2023, 9(11): 937-954. [4] Park S, Jang WJ, Jeong CH.Nano-biomechanical validation of epithelial-mesenchymal transition in oral squamous cell carcinomas[J]. Biol Pharm Bull, 2016, 39(9): 1488-1495. [5] Fuhs T, Wetzel F, Fritsch AW, et al.Rigid tumours contain soft cancer cells[J]. Nat Phys, 2022, 18(12): 1510-1519. [6] Rianna C, Radmacher M, Kumar S.Direct evidence that tumor cells soften when navigating confined spaces[J]. Mol Biol Cell, 2020, 31(16): 1726-1734. [7] Zhang Y, Fu Q, Sun W, et al.Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches[J]. J Transl Med, 2025, 23(1): 313. [8] Yang YA, Nguyen E, Sankara Narayana GHN, et al. Local contractions regulate E-cadherin rigidity sensing [J]. Sci Adv, 2022, 8(4): eabk0387. [9] Hartmann B, Fleischhauer L, Nicolau M, et al.Profiling native pulmonary basement membrane stiffness using atomic force microscopy[J]. Nat Protoc, 2024, 19(5): 1498-1528. [10] 衡扬, 闫加奇, 俞文强, 等. 细胞力学特性测量方法及应用[J]. 中国科学: 生命科学, 2023, 53(9): 1247-1273. Heng Y, Yan JQ, Yu WQ, et al.Measurement methods and application of mechanical properties of cells[J]. Scientia Sinica(Vitae), 2023, 53(9): 1247-1273. [11] Lekka M.Applicability of atomic force microscopy to determine cancer-related changes in cells[J]. Philos Trans A Math Phys Eng Sci, 2022, 380(2232): 20210346. [12] Skverchinskaya E, Levdarovich N, Ivanov A, et al.Anticancer drugs paclitaxel, carboplatin, doxorubicin, and cyclophosphamide alter the biophysical characteristics of red blood cells, in vitro[J]. Biology (Basel), 2023, 12(2): 230. [13] Jeffreys N, Brockman JM, Zhai Y, et al.Mechanical forces amplify TCR mechanotransduction in T cell activation and function[J]. Appl Phys Rev, 2024, 11(1): 011304. [14] Si J, Wang C, Zhang D, et al.Osteopontin in bone metabolism and bone diseases[J]. Med Sci Monit, 2020, 26: e919159. [15] Zhang B, Luo Q, Mao X, et al.A synthetic mechano-growth factor E peptide promotes rat tenocyte migration by lessening cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signaling pathway[J]. Exp Cell Res, 2014, 322(1): 208-216. [16] Harn HI, Wang YK, Hsu CK, et al.Mechanical coupling of cytoskeletal elasticity and force generation is crucial for understanding the migrating nature of keloid fibroblasts[J]. Exp Dermatol, 2015, 24(8): 579-584. [17] Ghosh B, Nishida K, Chandrala L, et al. Epithelial plasticity in COPD results in cellular unjamming due to an increase in polymerized actin [J]. J Cell Sci, 2022, 135(4): jcs258513. [18] Lv J, Liu Y, Cheng F, et al.Cell softness regulates tumorigenicity and stemness of cancer cells[J]. EMBO J, 2021, 40(2): e106123. [19] Swaminathan V, Mythreye K, O'Brien ET, et al. Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines[J]. Cancer Res, 2011, 71(15): 5075-5080. [20] Han YL, Pegoraro AF, Li H, et al.Cell swelling, softening and invasion in a three-dimensional breast cancer model[J]. Nat Phys, 2020, 16(1): 101-108. [21] Isert L, Passi M, Freystetter B, et al.Cellular EMT-status governs contact guidance in an electrospun TACS-mimicking in vitro model[J]. Mater Today Bio, 2025, 30: 101401. [22] Chen YQ, Lan HY, Wu YC, et al.Epithelial-mesenchymal transition softens head and neck cancer cells to facilitate migration in 3D environments[J]. J Cell Mol Med, 2018, 22(8): 3837-3846. [23] Kim DK, Kim EK, Jung DW, et al.Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts[J]. PLoS One, 2019, 14(3): e0214553. [24] Zhang JY, Zhu WW, Wang MY, et al.Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness[J]. J Transl Med, 2021, 19(1): 513. [25] Benn MC, Pot SA, Moeller J, et al. How the mechanobiology orchestrates the iterative and reciprocal ECM-cell cross-talk that drives microtissue growth [J]. Sci Adv, 2023, 9(13): eadd9275. [26] Li J, Xu J, Li L, et al.MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway[J]. Theranostics, 2020, 10(14): 6467-6482. [27] Torrino S, Grasset EM, Audebert S, et al. Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis [J]. Cell Metab, 2021, 33(7): 1342-1357.e10. [28] Chastney MR, Kaivola J, Leppänen VM, et al.The role and regulation of integrins in cell migration and invasion[J]. Nat Rev Mol Cell Biol, 2025, 26(2): 147-167. [29] Chien MH, Yang YC, Ho KH, et al.Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma[J]. Cell Death Dis, 2024, 15(1): 82. [30] Kellett MD, Sharma V, Sherlock ME, et al.Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival[J]. Front Oncol, 2025, 15: 1252544. [31] Wang JY, Chen H, Dai SZ, et al.Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity[J]. J Immunother Cancer, 2022, 10(3): e004344. [32] Orré T, Joly A, Karatas Z, et al.Molecular motion and tridimensional nanoscale localization of kindlin control integrin activation in focal adhesions[J]. Nat Commun, 2021, 12(1): 3104. [33] Pernier J, Cardoso dos Santos M, Souissi M, et al. Talin and kindlin cooperate to control the density of integrin clusters [J]. J Cell Sci, 2023, 136(8): jcs260746. [34] Lee JH, Son S, Ko Y, et al.Nidogen-1 suppresses cell proliferation, migration, and glycolysis via integrin β1-mediated HIF-1α downregulation in triple-negative breast cancer[J]. Sci Rep, 2025, 15(1): 10633. [35] Zeng G, Shen Y, Sun W, et al.Phenotype remodelling of HNSCC cells in the muscle invasion environment[J]. J Transl Med, 2024, 22(1): 909. [36] Wu Q, Chen P, Li J, et al.Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: a novel strategy for drug application[J]. Pharmacol Res, 2023, 188: 106654. [37] Rice A, Cortes E, Lachowski D, et al.GPER activation inhibits cancer cell mechanotransduction and basement membrane invasion via RhoA[J]. Cancers (Basel), 2020, 12(2): 289. [38] Terzi A, Maqoud F, Guido D, et al.Ion Channel-extracellular matrix interplay in colorectal cancer: a network-based approach to tumor microenvironment remodeling[J]. Int J Mol Sci, 2025, 26(11): 6189. [39] Yu Y, Wu X, Liu S, et al.Piezo1 regulates migration and invasion of breast cancer cells via modulating cell mechanobiological properties[J]. Acta Biochim Biophys Sin (Shanghai), 2021, 53(1): 10-18. [40] Arora C, Matic M, Bisceglia L, et al.The landscape of cancer-rewired GPCR signaling axes[J]. Cell Genom, 2024, 4(5): 100557. [41] Hasegawa K, Fujii S, Matsumoto S, et al.YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation[J]. J Pathol, 2021, 253(1): 80-93. [42] Liang X, Xu X, Wang F, et al.E-cadherin knockdown increases β-catenin reducing colorectal cancer chemosensitivity only in three-dimensional cultures[J]. Int J Oncol, 2015, 47(4): 1517-1527. [43] Delgado-Bellido D, Zamudio-Martínez E, Fernández-Cortés M, et al.VE-cadherin modulates β-catenin/TCF-4 to enhance vasculogenic mimicry[J]. Cell Death Dis, 2023, 14(2): 135. [44] Duong CN, Brückner R, Schmitt M, et al. Force-induced changes of α-catenin conformation stabilize vascular junctions independently of vinculin [J]. J Cell Sci, 2021, 134(24): jcs259012. [45] Chow KH, Factor RE, Ullman KS.The nuclear envelope environment and its cancer connections[J]. Nat Rev Cancer, 2012, 12(3): 196-209. [46] Nader GPF, Agüera-González S, Routet F, et al. Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion [J]. Cell, 2021, 184(20): 5230-5246.e22. [47] Jiao S, Li C, Guo F, et al.SUN1/2 controls macrophage polarization via modulating nuclear size and stiffness[J]. Nat Commun, 2023, 14(1): 6416. [48] Wang TC, Abolghasemzade S, McKee BP, et al. Matrix stiffness drives drop-like nuclear deformation and lamin A/C tension-dependent YAP nuclear localization[J]. Nat Commun, 2024, 15(1): 10151. [49] Fischer T, Hayn A, Mierke CT.Effect of nuclear stiffness on cell mechanics and migration of human breast cancer cells[J]. Front Cell Dev Biol, 2020, 8: 393. [50] Northcott JM, Dean IS, Mouw JK, et al.Feeling stress: the mechanics of cancer progression and aggression[J]. Front Cell Dev Biol, 2018, 6: 17. [51] Bertero T, Oldham WM, Grasset EM, et al. Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy[J]. Cell Metab, 2019, 29(1): 124-140.e10. [52] Lei K, Kurum A, Kaynak M, et al.Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy[J]. Nat Biomed Eng, 2021, 5(12): 1411-1425. [53] Zhang A, Miao K, Sun H, et al.Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance[J]. Int J Biol Sci, 2022, 18(7): 3019-3033. [54] Darvishi B, Eisavand MR, Majidzadeh-A K, et al.Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance[J]. Br J Cancer, 2022, 126(9): 1253-1263. [55] Liang R, Song G.Matrix stiffness-driven cancer progression and the targeted therapeutic strategy[J]. Mechanobiol Med, 2023, 1(2): 100013. [56] Wang Y, Jiang H, Su Z, et al.The drug resistance feature of acute myeloid leukemia is related to the cell stiffness[J]. Biophys Rev (Melville), 2025, 6(2): 021402. [57] Moreira D, Sampath S, Won H, et al.Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity[J]. J Clin Invest, 2021, 131(2): e137001. [58] Krupar R, Hautmann MG, Pathak RR, et al.Immunometabolic determinants of chemoradiotherapy response and survival in head and neck squamous cell carcinoma[J]. Am J Pathol, 2018, 188(1): 72-83. [59] Zhang T, Jia Y, Yu Y, et al.Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy[J]. Adv Drug Deliv Rev, 2022, 186: 114319. [60] Zhang Y, Li J, Guo X, et al.Tumor-specific MHC-II Activates CD4+ and CD8+ T cells in head and neck squamous cell carcinoma to boost immunotherapy efficacy[J]. Cancer Res, 2025, 85(17): 3258-3274. [61] Balachandran VP, Beatty GL, Dougan SK.Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities[J]. Gastroenterology, 2019, 156(7): 2056-2072. [62] Bonner M, Askew D, Sathish Kumar V, et al.Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells[J]. J Immunother Cancer, 2025, 13(6): e011815. [63] Yanamandra AK, Zhang J, Montalvo G, et al.PIEZO1-mediated mechanosensing governs NK-cell killing efficiency and infiltration in three-dimensional matrices[J]. Eur J Immunol, 2024, 54(3): e2350693. [64] Haage A, Schneider IC.Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells[J]. FASEB J, 2014, 28(8): 3589-3599. [65] Fan X, Chen H, Li Y, et al.Actin-targeted magnetic nanomotors mechanically modulate the tumor mechanical microenvironment for cancer treatment[J]. ACS Nano, 2025, 19(6): 6454-6467. [66] Su Y, Huang H, Luo T, et al.Cell-in-cell structure mediates in-cell killing suppressed by CD44[J]. Cell Discov, 2022, 8(1): 35. |